Pharma sales growth on double-digit track, back to pre-GST disruption level

Among top Indian players, Delhi based-Mankind Pharma showed the highest growth at 17.9%

After tepid single-digit growth in August and September, the Indian pharmaceutical industry is back on the double-digit track on strong anti-infectives and respiratory segments growth.    

According to data from AWACS, the market research wing of the All India Organisation of Chemists and Druggists (AIOCD), which represents over 550,000 medicine sellers across the country, the pharma market clocked 12.2 per cent year-on-year growth in October, against 7.5 per cent in September and 8.7 per cent in August. In total, the industry registered sales of Rs 117.6 billion for the month. 

"Volume growth seems to have resumed to pre-GST disruption levels. Anti-infectives